Reports of Biochemistry
and Molecular Biology
Mon, Jan 20, 2025
[Archive]
Volume 13, Issue 2 (Vol.13 No.2 Jul 2024)
rbmb.net 2024, 13(2): 273-280 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saljooghi S, Juybar M, Shahraki M, Ghasemi M, Payandeh A, Saravani* M. A Comparison of Apelin Rs56204867 and Apelin Receptor Rs11544374 Gene Polymorphisms and Their Association with Risk of
Preeclampsia in Southeast Iran. rbmb.net 2024; 13 (2) :273-280
URL: http://rbmb.net/article-1-1428-en.html
URL: http://rbmb.net/article-1-1428-en.html
Shaghayegh Saljooghi 
, Maryam Juybar , Mansour Shahraki , Marzieh Ghasemi * , Abolfazl Payandeh , Mohsen Saravani*
, Maryam Juybar , Mansour Shahraki , Marzieh Ghasemi * , Abolfazl Payandeh , Mohsen Saravani*
Department of Obstetrics and Gynecology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Abstract: (52 Views)
Background: Pre-eclampsia (PE) is a severe pregnancy condition with genetic and environmental factors affecting the placental function and vascular changes. Genetic variants in the apelinergic system may influence preeclampsia risk and birth outcomes. Therefore, this study aimed to compare apelin (APLN) rs56204867 and apelin receptor (APLNR) rs11544374 gene polymorphisms and to investigate their association with mothers’ body mass index and infant's birth weight among women with preeclampsia and control group in southeast Iran.
Methods: A total of 123 PE patients and 125 age- and gender-matched control subjects were enrolled in the study. The PCR–RFLP method was employed to genotype the APLN rs56204867 and APLNR rs11544374 gene polymorphisms.
Results: There was no significant association between the genotypes of the rs11544374 variant and the PE risk. The incidence of the AG genotype of the rs54204867 variant in the control group was considerably greater than in the PE group. Also, a significant relationship was found between the body mass profile of patients with PE and the APLN rs54204867 gene polymorphism.
Conclusions: It was observed that the APLN rs54204867 gene polymorphism could affect the PE risk. No significant difference was found between the PE group and the control group in terms of the genotypes of the APLNR rs 11544374 variant. It was not statistically significant between mothers' BMI and rs11544374 of the APLNR gene, whereas an obvious link was observed between Mothers' BMI and rs54204867 of the APLN gene.
Methods: A total of 123 PE patients and 125 age- and gender-matched control subjects were enrolled in the study. The PCR–RFLP method was employed to genotype the APLN rs56204867 and APLNR rs11544374 gene polymorphisms.
Results: There was no significant association between the genotypes of the rs11544374 variant and the PE risk. The incidence of the AG genotype of the rs54204867 variant in the control group was considerably greater than in the PE group. Also, a significant relationship was found between the body mass profile of patients with PE and the APLN rs54204867 gene polymorphism.
Conclusions: It was observed that the APLN rs54204867 gene polymorphism could affect the PE risk. No significant difference was found between the PE group and the control group in terms of the genotypes of the APLNR rs 11544374 variant. It was not statistically significant between mothers' BMI and rs11544374 of the APLNR gene, whereas an obvious link was observed between Mothers' BMI and rs54204867 of the APLN gene.
Type of Article: Original Article |
Subject:
Molecular Biology
Received: 2024/07/10 | Accepted: 2024/11/24 | Published: 2025/01/4
Received: 2024/07/10 | Accepted: 2024/11/24 | Published: 2025/01/4
References
1. Qu H, Khalil RA. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. Am J Physiol Heart Circ Physiol. 2020;319(3):H661-H681. [DOI:10.1152/ajpheart.00202.2020] [PMID] []
2. Garrido-Gómez T, Castillo-Marco N, Cordero T, Simón C. Decidualization resistance in the origin of preeclampsia. Am J Obstet Gynecol. 2022;226(2s):S886-s94. [DOI:10.1016/j.ajog.2020.09.039] [PMID]
3. Gandham R, Dayanand CD, Sheela SR, Kiranmayee P. Maternal serum Apelin 13 and APLN gene promoter variant -1860T > C in preeclampsia. J Matern Fetal Neonatal Med. 2022;35(25):5008-16. [DOI:10.1080/14767058.2021.1874341] [PMID]
4. Honigberg MC, Truong B, Khan RR, Xiao B, Bhatta L, Vy HMT, et al. Polygenic prediction of preeclampsia and gestational hypertension. Nat Med. 2023;29(6):1540-9. [DOI:10.1038/s41591-023-02374-9] [PMID] []
5. Rasmussen M, Reddy M, Nolan R, Camunas-Soler J, Khodursky A, Scheller NM, et al. RNA profiles reveal signatures of future health and disease in pregnancy. Nature. 2022;601(7893):422-7. [DOI:10.1038/s41586-021-04249-w] [PMID] []
6. Ardissino M, Slob EAW, Millar O, Reddy RK, Lazzari L, Patel KHK, et al. Maternal Hypertension Increases Risk of Preeclampsia and Low Fetal Birthweight: Genetic Evidence From a Mendelian Randomization Study. Hypertension. 2022;79(3):588-98. [DOI:10.1161/HYPERTENSIONAHA.121.18617] [PMID] []
7. Chatterjee P, Gheblawi M, Wang K, Vu J, Kondaiah P, Oudit GY. Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications. Clin Sci (Lond). 2020;134(17):2319-36. [DOI:10.1042/CS20200479] [PMID]
8. Estienne A, Bongrani A, Reverchon M, Ramé C, Ducluzeau PH, Froment P, Dupont J. Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models. Int J Mol Sci. 2019;20(18). [DOI:10.3390/ijms20184431] [PMID] []
9. Janssens P, Decuypere JP, Bammens B, Llorens-Cortes C, Vennekens R, Mekahli D. The emerging role of the apelinergic system in kidney physiology and disease. Nephrol Dial Transplant. 2022;37(12):2314-26. [DOI:10.1093/ndt/gfab070] [PMID]
10. Gilbert JS. From apelin to exercise: emerging therapies for management of hypertension in pregnancy. Hypertens Res. 2017;40(6):519-25. [DOI:10.1038/hr.2017.40] [PMID]
11. Liu Y, Wang L, Shi H. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia. Hypertens Res. 2019;42(7):928-34. [DOI:10.1038/s41440-018-0193-3] [PMID]
12. Pécheux O, Correia-Branco A, Cohen M, Martinez de Tejada B. The Apelinergic System in Pregnancy. Int J Mol Sci. 2023;24(9). [DOI:10.3390/ijms24098014] [PMID] []
13. Liao YC, Chou WW, Li YN, Chuang SC, Lin WY, Lakkakula BV, et al. Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women. Am J Clin Nutr. 2011;94(3):921-8. [DOI:10.3945/ajcn.110.008813] [PMID]
14. Zhou Q, Cao J, Chen L. Apelin/APJ system: A novel therapeutic target for oxidative stress-related inflammatory diseases (Review). Int J Mol Med. 2016;37(5):1159-69. [DOI:10.3892/ijmm.2016.2544] [PMID]
15. Hamza RZ, Diab AAA, Zahra MH, Asalah AK, Moursi SMM, Al-Baqami NM, et al. Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta. Int J Endocrinol. 2021;2021:5017362. [DOI:10.1155/2021/5017362] [PMID] []
16. Van Mieghem T, Doherty A, Baczyk D, Drewlo S, Baud D, Carvalho J, Kingdom J. Apelin in Normal Pregnancy and Pregnancies Complicated by Placental Insufficiency. Reprod Sci. 2016;23(8):1037-43. [DOI:10.1177/1933719116630422] [PMID]
17. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-31.
18. Rezaei M, Ghasemi M, Saravani M, Ghahghayi F, Shahraki-Ghadim H, Salimi S. The possible effects of the MTOR polymorphisms on preeclampsia susceptibility, severity, and onset: a case-control study and in silico analysis. Mol Biol Rep. 2024;51(1):335. [DOI:10.1007/s11033-023-09190-x] [PMID]
19. Mamdouh Shoeib S, Elwy Abdeldaim D, Samir Mashal S, Raafat Ibrahim R, Mohamed Dawood L, Shatat D, et al. The Ratio of Cysteine-Rich Angiogenic Inducer 61 to MicroRNA -155 Expression as a Preeclampsia Diagnostic Marker and Predictor of Its Severity. Rep Biochem Mol Biol. 2023 Jul;12(2):332-339. [DOI:10.61186/rbmb.12.2.332] [PMID] []
20. Mortazavi A, Nematipoor E, Djalali M, Keshavarz SA, Samavat S, Zarei M, Javanbakht MH. The Effect of Omega-3 Fatty Acids on Serum Apelin Levels in Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial. Rep Biochem Mol Biol. 2018 Oct;7(1):59-66.
21. Wang T, Liu C, Jia L, Ding J. The association between apelin polymorphisms and hypertension in China: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2019;20(1):1470320319827204. [DOI:10.1177/1470320319827204] [PMID] []
22. Huang F, Zhu P, Huang Q, Yuan Y, Lin F, Li Q. Associations between gene polymorphisms of the apelin-APJ system and the risk of hypertension. Blood Press. 2016;25(4):257-62. [DOI:10.3109/08037051.2016.1156905] [PMID]
23. Li Y, Liu A, Song J, Zhang Z, Zhang Q. Association of genetic defects in the apelin-AGTRL1 system with myocardial infarction risk in Han Chinese. Gene. 2021;766:145143. [DOI:10.1016/j.gene.2020.145143] [PMID]
24. Esteban-Martínez RL, Pérez-Razo JC, Vargas-Alarcón G, Martínez-Rodríguez N, Cano-Martínez LJ, López-Hernández LB, et al. Polymorphisms of APLN-APLNR system are associated with essential hypertension in Mexican-Mestizo individuals. Exp Mol Pathol. 2016;101(1):105-9. [DOI:10.1016/j.yexmp.2016.07.007] [PMID]
25. Zhu P, Lin F, Huang F, Huang Q, Li Q, Gao Z, Chen F. Apelin and APLN single nucleotide polymorphisms and combined hypertension and central retinal artery stenosis in a Chinese population. Clin Exp Hypertens. 2015;37(4):280-7. [DOI:10.3109/10641963.2014.960970] [PMID]
26. Jin W, Su X, Xu M, Liu Y, Shi J, Lu L, Niu W. Interactive association of five candidate polymorphisms in Apelin/APJ pathway with coronary artery disease among Chinese hypertensive patients. PLoS One. 2012;7(12):e51123. [DOI:10.1371/journal.pone.0051123] [PMID] []
27. Wu XD, Zhang N, Liang M, Liu WL, Lin BB, Xiao YR, et al. Gender-specific association between Apelin/APJ gene polymorphisms and hypertension risk in Southeast China. Gene. 2018;669:63-8. [DOI:10.1016/j.gene.2018.05.079] [PMID]
28. Liu R, Zhao H, Wang Y, Wang Y, Lu C, Xiao Y, et al. The contributory role of angiotensin receptor-like 1 gene multiple polymorphisms in hypertension among northeastern Han Chinese. PLoS One. 2014;9(1):e86095. [DOI:10.1371/journal.pone.0086095] [PMID] []
29. Nowzari Z, Masoumi M, Nazari-Robati M, Akbari H, Shahrokhi N, Asadikaram G. Association of polymorphisms of leptin, leptin receptor and apelin receptor genes with susceptibility to coronary artery disease and hypertension. Life Sci. 2018;207:166-71. [DOI:10.1016/j.lfs.2018.06.007] [PMID]
30. Zhang M, Peng F, Lin L, Yu M, Huang C, Hu D, et al. Association study of apelin-APJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a case-control study. Oncotarget. 2019;10(38):3807-17. [DOI:10.18632/oncotarget.24111] [PMID] []
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
